BSEInsider Trading / SAST6 Oct 2026 · 6 Oct 2026, 04:27 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pratap Dadasaheb Deshmukh & PACs
iSERA Lifesciences Ltd · 534920
✦ AI SummaryRegulatory
iSERA Lifesciences Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pratap Dadasaheb Deshmukh & PACs.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
iSERA Lifesciences Ltd - 534920 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011